ZA872166B - Synthetic htlv-iii peptides,compositions and uses thereof - Google Patents

Synthetic htlv-iii peptides,compositions and uses thereof

Info

Publication number
ZA872166B
ZA872166B ZA872166A ZA872166A ZA872166B ZA 872166 B ZA872166 B ZA 872166B ZA 872166 A ZA872166 A ZA 872166A ZA 872166 A ZA872166 A ZA 872166A ZA 872166 B ZA872166 B ZA 872166B
Authority
ZA
South Africa
Prior art keywords
compositions
htlv
iii peptides
synthetic
synthetic htlv
Prior art date
Application number
ZA872166A
Other languages
English (en)
Inventor
Jonathan I Rosen
I Rosen Jonathan
Robert B Naso
B Naso Robert
Ralph B Arlinghaus
B Arlinghaus Ralph
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25289969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA872166(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of ZA872166B publication Critical patent/ZA872166B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
ZA872166A 1986-03-24 1987-03-24 Synthetic htlv-iii peptides,compositions and uses thereof ZA872166B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84343786A 1986-03-24 1986-03-24

Publications (1)

Publication Number Publication Date
ZA872166B true ZA872166B (en) 1988-10-26

Family

ID=25289969

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872166A ZA872166B (en) 1986-03-24 1987-03-24 Synthetic htlv-iii peptides,compositions and uses thereof

Country Status (8)

Country Link
EP (1) EP0261224B2 (de)
JP (1) JPS63502904A (de)
AT (1) ATE98376T1 (de)
AU (3) AU7234387A (de)
DE (1) DE3788397T3 (de)
DK (1) DK175901B1 (de)
WO (1) WO1987006005A1 (de)
ZA (1) ZA872166B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
AU1334588A (en) * 1987-03-23 1988-09-22 Ortho Pharmaceutical Corporation Assay for detecting hepatitis antigens and aids antibodies
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
AU623097B2 (en) * 1987-10-09 1992-05-07 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
EP0323157A3 (de) * 1987-12-24 1990-07-25 The University Of Melbourne Antivirale Verbindungen und Methoden
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US6218102B1 (en) 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
EP0328390B1 (de) * 1988-02-10 1994-09-14 Immulogic Pharmaceutical Corporation Peptidbehandlung von hartnäckigen Infektionskrankheiten
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
US5268299A (en) * 1988-04-14 1993-12-07 Eastman Kodak Company Diluent composition useful in the detection of antibodies in assays
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
EP0362910A3 (de) * 1988-08-27 1991-01-09 Akzo N.V. Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
ATE162799T1 (de) * 1989-06-02 1998-02-15 Genetic Systems Corp Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
DE69326069T2 (de) * 1992-07-20 2000-03-23 Univ Durham Zusammensetzungen die die hiv replikation inhibieren
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
DE19720914A1 (de) * 1997-05-16 1998-11-19 Boehringer Mannheim Gmbh Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene
WO2010085763A1 (en) * 2009-01-23 2010-07-29 Inova Diagnostics, Inc. Methods for detecting antibodies associated with autoimmune diseases utilizing a three dimensionally heterogeneous peptide antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2705791B2 (ja) * 1985-04-29 1998-01-28 ジエネテイツク システムズ コ−ポレイシヨン Ａｉｄｓ関連病の検出のための合成抗原
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法

Also Published As

Publication number Publication date
AU1130392A (en) 1992-06-04
EP0261224B1 (de) 1993-12-08
EP0261224A1 (de) 1988-03-30
DK614987A (da) 1987-11-23
JPS63502904A (ja) 1988-10-27
DK614987D0 (da) 1987-11-23
DE3788397T2 (de) 1994-06-01
AU7234387A (en) 1987-10-20
DK175901B1 (da) 2005-05-30
AU8172094A (en) 1995-03-23
EP0261224B2 (de) 2003-03-26
ATE98376T1 (de) 1993-12-15
DE3788397D1 (de) 1994-01-20
DE3788397T3 (de) 2003-11-27
EP0261224A4 (de) 1989-07-06
WO1987006005A1 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
EP0220273A4 (de) Synthetische antigene zum nachweis von aids.
EA199800946A1 (ru) Концентрированный препарат антител
IL78696A0 (en) Synthetic peptide and process of using same for the detection of antibodies to htlv-iii,diagnosis of aids and pre-aids conditions and as a vaccine
NZ333744A (en) Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
EP0267802A3 (de) Synthetisches Antigen zum Nachweis von mit AIDS in Zusammenhang stehenden Krankheiten
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
AR227021A1 (es) Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado
JPS557287A (en) Aryloxypropanol amine
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
AP9100291A0 (en) Synthetic peptides and mixtures therof for detecting HIV antibodies.
FI874273A (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
AU635124B2 (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
ES2062754T3 (es) Eliminacion de linfocitos activados.
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
JPS53127808A (en) Preparation of human albumin
EP0241004A3 (en) Chromophoric peptides, process for their preparation and their use to identify peptidylglycin-alpha-amidifying monooxygenase
IT1213576B (it) Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
AU646275C (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
JPS6471488A (en) Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов